Vid Desai FDA’s Chief Information Officer | Official Website
Vid Desai FDA’s Chief Information Officer | Official Website
This is a 40% decrease from the number of companies cited in the previous year.
Of the 97 citations issued, the most common citation was 'You did not develop an FSVP'.
Most of the companies cited were involved in the Food and Cosmetics sector. The second most common type of company cited in the time period worked in the the Biologics sector.
Of the companies cited, 37 should take voluntary actions to correct their managing operations (94.9%). Additionally, two companies had to take regulatory and/or administrative actions (5.1%).
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
A Life Wholesale | Food and Cosmetics | 10/10/2023 | Develop FSVP |
Aaron Gourmet Food Imports, Inc. | Food and Cosmetics | 06/01/2023 | Very small importer assurances, supplier |
Americord Registry, LLC | Biologics | 01/13/2023 | Approval and review of procedures |
Americord Registry, LLC | Biologics | 01/13/2023 | Validation lacking for sterile drug products |
Americord Registry, LLC | Biologics | 01/13/2023 | Scientifically sound laboratory controls |
Americord Registry, LLC | Biologics | 01/13/2023 | Microbiological testing |
Americord Registry, LLC | Biologics | 01/13/2023 | Dates not included for each significant step |
Americord Registry, LLC | Biologics | 01/13/2023 | Testing, screening, donor eligibility procedures |
Americord Registry, LLC | Biologics | 01/13/2023 | Risk factors, clinical evidence |
Americord Registry, LLC | Biologics | 01/13/2023 | Birth mother sample not tested |
Americord Registry, LLC | Biologics | 01/13/2023 | All core requirements covered in program |
Americord Registry, LLC | Biologics | 01/13/2023 | Deviations--Investigation, documenting, trending |
Americord Registry, LLC | Biologics | 01/13/2023 | Documentation of maintenance and cleaning |
Americord Registry, LLC | Biologics | 01/13/2023 | Verification/validation |
Americord Registry, LLC | Biologics | 01/13/2023 | Process validation procedures |
Americord Registry, LLC | Biologics | 01/13/2023 | Accurate, indelible, legible |
Americord Registry, LLC | Biologics | 01/13/2023 | Records incomplete |
Amorino Trading, LLC | Food and Cosmetics | 03/02/2023 | Develop FSVP |
Applevalley Organics, Corporation, Inc. | Veterinary | 08/16/2023 | Develop FSVP |
BonBon NYC, LLC. | Food and Cosmetics | 02/24/2023 | Very small importer assurances, supplier |
Coosemans New York, Inc. | Food and Cosmetics | 02/24/2023 | Develop FSVP |
Coosemans New York, Inc. | Food and Cosmetics | 02/24/2023 | Raw agricultural commodity hazard |
Crown Fish, LLC | Food and Cosmetics | 10/24/2023 | Critical limits |
Crown Fish, LLC | Food and Cosmetics | 10/24/2023 | Monitoring - adequacy |
Crown Fish, LLC | Food and Cosmetics | 10/24/2023 | Corrective action plan |
Crown Fish, LLC | Food and Cosmetics | 10/24/2023 | Sanitation monitoring |
Delsam Pharma, LLC | Drugs | 03/24/2023 | Lack of quality control unit |
Delsam Pharma, LLC | Drugs | 03/24/2023 | Storage under appropriate conditions |
Delsam Pharma, LLC | Drugs | 03/24/2023 | Recall facilitation |
Delsam Pharma, LLC | Drugs | 03/24/2023 | Items to cover on annual reviews |
Delsam Pharma, LLC | Drugs | 03/24/2023 | Procedures to be written and followed |
E. Armata, Inc. | Food and Cosmetics | 03/21/2023 | Develop FSVP |
Eileen's Special Cheesecake, Inc. | Food and Cosmetics | 01/24/2023 | Pest control |
Eye Bank For Sight Restoration, Inc. | Biologics | 11/13/2023 | Adequate control, proper conditions |
Eye Bank For Sight Restoration, Inc. | Biologics | 11/13/2023 | Use prior to verification |
Eye Bank For Sight Restoration, Inc. | Biologics | 11/13/2023 | Accurate, indelible, legible |
Eye Bank For Sight Restoration, Inc. | Biologics | 11/13/2023 | Records incomplete |
Eye Bank For Sight Restoration, Inc. | Biologics | 11/13/2023 | Records maintained concurrently |
G21 USA, Inc. | Devices | 07/25/2023 | Training - Lack of or inadequate procedures |
G21 USA, Inc. | Devices | 07/25/2023 | Lack of or inadequate procedures |
G21 USA, Inc. | Devices | 07/25/2023 | Lack of or inadequate complaint procedures |
Gurum Corporation | Food and Cosmetics | 08/15/2023 | Develop FSVP |
J Margiotta Company, LLC | Food and Cosmetics | 01/31/2023 | Develop FSVP |
J&H Imports Services Corporation | Food and Cosmetics | 08/02/2023 | Develop FSVP |
Juice Press, LLC | Food and Cosmetics | 03/14/2023 | Develop FSVP |
Kofinas Fertility Group | Biologics | 07/25/2023 | Determination based on screening and testing |
Kofinas Fertility Group | Biologics | 07/25/2023 | Responsible person to determine, document |
Kofinas Fertility Group | Biologics | 07/25/2023 | Accurate, indelible, legible |
Kyewaa, LLC | Food and Cosmetics | 12/19/2023 | Develop FSVP |
LA Dulceria, Inc. | Food and Cosmetics | 02/08/2023 | Develop FSVP |
MTV Foods | Food and Cosmetics | 09/08/2023 | Importer verification |
Manhattan Fertility Services, LLC | Biologics | 04/06/2023 | Labeled re: biohazard, risks, test results |
Manhattan Fertility Services, LLC | Biologics | 04/06/2023 | Risk factors, clinical evidence |
Molino Food Livel, Corp. | Food and Cosmetics | 09/11/2023 | Very small importer assurances, supplier |
Montefiore Medical Center Blood Bank | Biologics | 05/18/2023 | Qualifications of responsible personnel |
Montefiore Medical Center Blood Bank | Biologics | 05/18/2023 | Establish, maintain and follow manufacturing SOPs |
Montefiore Medical Center Blood Bank | Biologics | 05/18/2023 | Concurrent documentation |
Mrinal M. Gounder, M.D. | Drugs | 03/03/2023 | FD-1572, protocol compliance |
Mrinal M. Gounder, M.D. | Drugs | 03/03/2023 | Safety Reports - Serious Events |
N. Y. S. Psychiatric Institute IRB | Drugs | 02/02/2023 | ClincialTrials.gov statement |
N. Y. S. Psychiatric Institute IRB | Drugs | 02/02/2023 | Prompt reporting of unanticipated problems |
N. Y. S. Psychiatric Institute IRB | Drugs | 02/02/2023 | Prompt reporting of noncompliance |
N. Y. S. Psychiatric Institute IRB | Drugs | 02/02/2023 | Members present for review |
N. Y. S. Psychiatric Institute IRB | Drugs | 02/02/2023 | Minor changes |
New Hope Fertility Center | Biologics | 03/03/2023 | Responsible person to determine, document |
New Hope Fertility Center | Biologics | 03/03/2023 | Completion of eligibility determination |
New Hope Fertility Center | Biologics | 03/03/2023 | Eligibility not required--warning labels |
New York Blood Center Enterprises | Biologics | 07/06/2023 | Maintenance - tracing |
New York Blood Center Enterprises | Biologics | 07/06/2023 | When to report |
New York Blood Center Enterprises | Biologics | 07/06/2023 | Following manufacturer's instructions |
New York Blood Center Enterprises | Biologics | 07/06/2023 | Establish, maintain and follow manufacturing SOPs |
New York Blood Center Enterprises | Biologics | 07/06/2023 | Thorough investigations |
New York Blood Center Enterprises | Biologics | 07/06/2023 | Required records |
New York Presbyterian Hospital-Columbia University Med. Center | Biologics | 11/28/2023 | Equipment observed, standardized, calibrated |
New York Presbyterian Hospital-Columbia University Med. Center | Biologics | 11/28/2023 | Establish, maintain and follow manufacturing SOPs |
New York Presbyterian Hospital-Columbia University Med. Center | Biologics | 11/28/2023 | Concurrent documentation |
New York Presbyterian Hospital-Columbia University Med. Center | Biologics | 11/28/2023 | Required records |
Pinnacle Fertility Labs New York | Biologics | 12/14/2023 | Testing, screening, donor eligibility procedures |
Ports America, Inc. | Food and Cosmetics | 10/10/2023 | Prevention of contamination |
Ports America, Inc. | Food and Cosmetics | 10/10/2023 | Signs for non-potable water |
Reyes Produce Corporation | Food and Cosmetics | 03/17/2023 | Develop FSVP |
Shneiders USA, Inc. | Food and Cosmetics | 01/19/2023 | Develop FSVP |
Sojitz Corporation of America | Veterinary | 08/11/2023 | Develop FSVP |
Sojitz Corporation of America | Veterinary | 08/11/2023 | Record - translate to English |
Sweet Sam's Baking Company, LLC | Food and Cosmetics | 07/20/2023 | Personnel |
Sweet Sam's Baking Company, LLC | Food and Cosmetics | 07/20/2023 | Pest control |
TMRW Life Sciences, Inc. | Devices | 10/24/2023 | DHR - not or inadequately maintained |
Wako Inflight Service, Inc. | Food and Cosmetics | 03/01/2023 | Cleaning and sanitizing substances - Safe and adequate |
Wako Inflight Service, Inc. | Food and Cosmetics | 03/01/2023 | Manufacturing, processing, packing, holding - Controls |
Wako Inflight Service, Inc. | Food and Cosmetics | 03/01/2023 | Calibration - adequacy |
Wako Inflight Service, Inc. | Food and Cosmetics | 03/01/2023 | Plumbing design, installation, maintenance |
Wako Inflight Service, Inc. | Food and Cosmetics | 03/01/2023 | Maintained in good repair |
Wild Edibles, Inc. | Food and Cosmetics | 12/07/2023 | HACCP plan implementation |
Wild Edibles, Inc. | Food and Cosmetics | 12/07/2023 | Sanitation monitoring |
Xtreem Pulse, LLC | Devices | 10/13/2023 | Design changes - Lack of or Inadequate Procedures |
Xtreem Pulse, LLC | Devices | 10/13/2023 | Design history file |
Xtreem Pulse, LLC | Devices | 10/13/2023 | Lack of or inadequate receiving acceptance procedures |